UNSPSC 51391615: Isometheptene mucate

This classification denotes an adrenergic agent with the molecular formula 2C9H19N.C6H10O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8O120FDS6P. European Medicines Agency schedules isometheptene mucate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02792MIG. The term isometheptene mucate is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule isometheptene mucate under HS 29211980 and SITC 51451.

As of Q4 2014, ISOMETHEPTENE MUCATE remains US FDA's Preferred Term for this commodity. Isometheptene mucate bears US NLM identifiers UMLS ID C0355634 and NCI Concept Code C87577. SMILES: CC(CCC=C(C)C)NC.CC(CCC=C(C)C)NC.[C@@H]([C@@H]([C@H](C(=O)O)O)O)([C@@H](C(=O)O)O)O.

UNSPSC 51391615 Isometheptene mucate is a Commodity code that nominally designates a specific pharmaceutical ingredient, but recent state and local procurement activity under this code shows a significant mismatch: the only recent opportunity tagged to it is Seminole County, Florida's IFB for naloxone and drug deactivation systems, which is a public health supply and harm-reduction procurement unrelated to isometheptene mucate. The code appears to see little relevant recent activity aligned with its nominal pharmaceutical scope. State and local procurement offices tagging opportunities to this code may be using it as a catch-all for pharmaceutical or medical supply procurements that do not fit narrower categories, or the opportunity record may carry an incorrect code assignment.

Seminole County's July 2026 IFB (IFB60459723LAS, response deadline July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required bidders to submit unit costs electronically, include all shipping and delivery costs in proposals, comply with drug-free workplace and E-Verify requirements, carry workers' compensation and commercial general liability insurance, and accept a three-month probationary termination clause. The contract structure included an initial two-year term with a one-year renewal option and was potentially funded through FEMA, introducing additional federal compliance obligations. This single recent opportunity does not support a robust characterization of issuing-body or geographic distribution under the code; business development professionals should verify code assignment when pursuing pharmaceutical or medical supply opportunities to ensure their solutions align with actual procurement intent.